NextCure Statistics
Total Valuation
NextCure has a market cap or net worth of $13.72 million. The enterprise value is -$48.70 million.
Important Dates
The last earnings date was Thursday, March 6, 2025, after market close.
| Earnings Date | Mar 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NextCure has 28.01 million shares outstanding. The number of shares has increased by 0.46% in one year.
| Current Share Class | 28.01M |
| Shares Outstanding | 28.01M |
| Shares Change (YoY) | +0.46% |
| Shares Change (QoQ) | +0.11% |
| Owned by Insiders (%) | 1.81% |
| Owned by Institutions (%) | 34.71% |
| Float | 21.07M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.21 |
| P/TBV Ratio | 0.21 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.50, with a Debt / Equity ratio of 0.09.
| Current Ratio | 7.50 |
| Quick Ratio | 7.20 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -61.87% and return on invested capital (ROIC) is -37.16%.
| Return on Equity (ROE) | -61.87% |
| Return on Assets (ROA) | -34.23% |
| Return on Invested Capital (ROIC) | -37.16% |
| Return on Capital Employed (ROCE) | -80.25% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.29M |
| Employee Count | 43 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -78.04% in the last 52 weeks. The beta is 0.71, so NextCure's price volatility has been lower than the market average.
| Beta (5Y) | 0.71 |
| 52-Week Price Change | -78.04% |
| 50-Day Moving Average | 0.72 |
| 200-Day Moving Average | 1.20 |
| Relative Strength Index (RSI) | 28.13 |
| Average Volume (20 Days) | 86,344 |
Short Selling Information
The latest short interest is 65,825, so 0.24% of the outstanding shares have been sold short.
| Short Interest | 65,825 |
| Short Previous Month | 67,454 |
| Short % of Shares Out | 0.24% |
| Short % of Float | 0.31% |
| Short Ratio (days to cover) | 1.50 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -57.21M |
| Pretax Income | -61.28M |
| Net Income | -55.65M |
| EBITDA | -54.34M |
| EBIT | -57.21M |
| Earnings Per Share (EPS) | -$1.99 |
Full Income StatementBalance Sheet
The company has $68.62 million in cash and $5.95 million in debt, giving a net cash position of $62.67 million or $2.24 per share.
| Cash & Cash Equivalents | 68.62M |
| Total Debt | 5.95M |
| Net Cash | 62.67M |
| Net Cash Per Share | $2.24 |
| Equity (Book Value) | 65.47M |
| Book Value Per Share | 2.34 |
| Working Capital | 62.23M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$40.81 million and capital expenditures -$474,000, giving a free cash flow of -$41.28 million.
| Operating Cash Flow | -40.81M |
| Capital Expenditures | -474,000 |
| Free Cash Flow | -41.28M |
| FCF Per Share | -$1.47 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |